Extraordinary SAGE meeting of 7 July 2009
Background documents and presentations
PRESENTATIONS
-
Update on epidemiology and disease burden - Sylvie Briand
pdf, 4.77Mb -
Overview of Pandemic Modelling - Neil Ferguson
pdf, 551kb -
Update on A(H1N1) pandemic and seasonal vaccine availability - Marie-Paule Kieny
pdf, 3.60Mb -
Update on strain availability, growth potential and availability of reagents - Wenqing Zhang
pdf, 968kb -
Timelines for availability of data to support licensure and licensing processes and timelines - David Wood
pdf, 1.36Mb -
Vaccine safety: output of the vaccine safety consultation and of the June GACVS meeting - Karen Midthun
pdf, 67kb -
Update on programmatic issues - Thomas Cherian
pdf, 2.08Mb
Background documents
SESSION: Epidemiology and disease burden
-
H1N1 clinical observations from Japan (World Epidemiological Record, WHO)
pdf, 543kb -
H1N1 clinical observations from Mexico (World Epidemiological Record, WHO)
pdf, 1.52Mb - 2008-2009 influenza epidemiology; seasonal and novel influenza A(H1N1) (CDC Presentation - Finelli)
- Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic (Smith 2009)
- Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans (CDC 2009)
-
Considerations for assessing severity (World epidemiological record, WHO)
pdf, 840kb - Severe Respiratory Disease Concurrent with the Circulation of H1N1 Influenza (Chowell et al 2009)
- Swine flu update: bringing home the bacon (Senanayake 2009)
-
California hospitalization (MMWR 22 May)
pdf, 381kb - Virology and immunology (CDC Presentation - Nancy Cox)
-
Risk factors for severe illness (GIP Presentation)
pdf, 213kb - Pandemic Influenza and pregnant women (Rasmunssen 2008)
-
Points to consider on antiviral resistance (Charles Penn)
pdf, 80kb - Signature features of an influenza pandemic – Implications for Policy (Miller et al 2009)
- Lessons for Europe from past pandemics and the North American experience (ECDC - Presentation)
- Transmission potential of the new A(H1N1) virus and its age-specificity in Japan (Nishiura et al 2009)
- Lessons from previous outbreaks (Stein 2009)
- Cross-Protection between Successive Waves of the 1918–1919 Influenza Pandemic: Epidemiological Evidence from US Army Camps and from Britain (Barry et al 2008)
-
Serum Cross-Reactive Antibody Response to a Novel Influenza A (H1N1) Virus After Vaccination with Seasonal Influenza Vaccine (MMWR 22 May)
pdf, 211kb
SESSION: Vaccine production and availability
SESSION: Vaccine safety, efficacy and regulatory issues
- Influenza Vaccine Effectiveness (CDC Presentation - Sanchez)
- Effectiveness of Maternal Influenza Immunization in Mothers and Infants (Zaman et al 2008)
- Summary of: WHO Virtual Consultation on the Safety of Adjuvanted Influenza Vaccines (WHO GAVCS 3 June 2009)
-
GAVCS report (WHO GAVCS 17 June 2009) - draft version, full version will be published in WER in due course
pdf, 25kb -
GBS and influenza vaccine (GACVS presentation - J. Sejvar)
pdf, 118kb - “Prepandemic” Immunization for Novel Influenza Viruses, “Swine Flu” Vaccine, Guillain-Barre´ Syndrome, and the Detection of Rare Severe Adverse Events (Evans, Cauchemez & Hayden 09)
- Influenza vaccination in pregnancy: current evidence and selected national policies (Mak T et al 2008)
- Is routine influenza immunization warranted in early pregnancy? (Skowronski 2009)
- Characteristics of the A(H1N1) virus and recommendations for vaccine development (WHO)
-
Availability of A(H1N1) vaccine viruses (WHO)
pdf, 12kb
SESSION: Programmatic Issues
- Review of existing vaccine prioritization guidance (CDC Presentation - Shimabukuros)
- Prioritization of vaccination to minimize years of life lost (Miller et al 2009)
Additional documents may be added pending granting of permission.
Last updated: 10 July 2009